ASF Center of Excellence

Explore the Angelman Syndrome Foundation Center of Excellence, offering comprehensive care, education, and support for individuals with Angelman Syndrome. Reach out for help today!
2023 Ultragenyx Update

Join the 2023 ASF Virtual Conference to learn about Ultragenyx’s latest developments in rare disease treatments, including the GTX-102 program for Angelman syndrome.
2023 Neuren Pharmaceuticals Update

Explore Neuren Pharmaceuticals’ latest updates on their clinical development program for Angelman Syndrome, including progress on Trofinetide and NNZ-2591 treatments.
2023 Ionis Pharmaceuticals Update

Explore Ionis Pharmaceuticals’ commitment to developing treatments for Angelman Syndrome, their progress in the HALOS clinical trial, and their dedication to genetic medicine.
2023 ASF Virtual Conference – Intro

Join the 2023 ASF Virtual Conference! Discover our achievements, future plans, and how you can help support the Angelman Syndrome Foundation. Enjoy at your convenience.
Transition Planning with Protected Tomorrows

Discover expert insights on transition planning for families with special needs from Mary Anne Ehlert. Learn about financial, legal, and support strategies for the future.
Toilet Training Tips & Tricks for Caregivers of Individuals with Developmental Disabilities

Discover effective toilet training strategies for individuals with developmental disabilities. Learn from experts on readiness, reinforcement, and achieving long-term success.
The Relationship Between Cortical Visual Impairment (CVI) and Communication

Explore the link between Cortical Visual Impairment and communication in children with disabilities. Learn about challenges, solutions, and Dr. Erickson’s research insights.
The Power of Advocacy

Discover the impact of advocacy in rare diseases with insights from Ryan Fischer at the 2024 ASF Family Conference. Learn how to drive change for Angelman Syndrome.
The Journey to Better Therapeutics

Join Dr. Rebecca Burdine’s inspiring journey at the 2024 ASF Family Conference, exploring breakthroughs in Angelman Syndrome research and future therapeutic developments.